Bladder Cancer

Featured

Guideline Updates
NCCN Updates Clinical Practice Guideline for Bladder Cancer
NCCN updated its clinical practice guideline for bladder cancer, removing atezolizumab as an alternative second-line systemic therapy option for locally advanced or metastatic…
Videos
Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-…
Guideline Updates
NCCN Updates Clinical Practice Guideline for Bladder Cancer
NCCN released an update to its clinical practice guideline for bladder cancer.
Videos
Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition…
Videos
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors…

News

External Beam Radiotherapy for Prostate Cancer Increases Bladder-Cancer Risk
Radical Cystectomy Versus Trimodal Therapy for Older Patients With Bladder Cancer
Trimodal Therapy vs Radical Cystectomy for Patients With Localized Bladder Cancer
NCCN Updates Guidelines for Bladder Cancer Management

Guideline Updates

NCCN Updates Clinical Practice Guideline for Bladder Cancer

Videos

Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma

Podcast

Episode 46: Advances in Bladder Cancer With Monty Pal
Back to Top